[1]钟琴,鲍梦婕,康林之,等.中医药治疗糖尿病周围神经病变的系统评价再评价[J].西部中医药,2022,35(11):98-103.[doi:10.12174/j.issn.2096-9600.2022.11.19]
　ZHONG Qin,BAO Mengjie,KANG Linzhi,et al.Re-evaluation of System Evaluation of TCM Therapy in the Treatment of Diabetic Peripheral Neuropathy[J].Western Journal of Traditional Chinese Medicine,2022,35(11):98-103.[doi:10.12174/j.issn.2096-9600.2022.11.19]
点击复制

中医药治疗糖尿病周围神经病变的系统评价再评价
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
35
期数:
2022年11期
页码:
98-103
栏目:
出版日期:
2022-11-15

文章信息/Info

Title:
Re-evaluation of System Evaluation of TCM Therapy in the Treatment of Diabetic Peripheral Neuropathy
作者:
钟琴, 鲍梦婕, 康林之, 江虹
江西中医药大学护理学院，江西 南昌 330004
Author(s):
ZHONG Qin, BAO Mengjie, KANG Linzhi, JIANG Hong
School of Nursing, Jiangxi University of Traditional Chinese Medicine, Nanchang 330004, China
关键词:
糖尿病; 周围神经病变; 系统评价再评价; AMSTAR工具; GRADE系统; 中医药
Keywords:
diabetes mellitus; peripheral neuropathy; re-evaluation of system evaluation; AMSTAR tool; GRADE system; TCM
分类号:
R587
DOI:
10.12174/j.issn.2096-9600.2022.11.19
文献标志码:
A
摘要:
目的对中医药治疗糖尿病周围神经病变的系统评价/Meta分析进行再评价。 方法系统检索Pubmed、Cochrane Library、Web of science、Medline complete、中国生物医学文献数据库（CMB）、中国知网（CNKI）、万方数据库（WanFang）及中国维普全文数据库（VIP）中中医药治疗糖尿病周围神经病变的系统评价/Meta分析文献，由2名研究者独立筛选文献并提取资料，采用AMSTAR和GRADE系统工具分别进行方法学质量和证据等级评价。 结果共纳入13篇系统评价/Meta分析文献，包括52个结局指标。AMSTAR工具评价结果显示，报告最差的条目为“是否提供前期设计方案”（12篇未提供），其次为条目“是否考虑检索灰色文献”（11篇不充分）与条目“是否说明相关利益冲突”（7篇未说明）。GRADE分级结果显示，5项结局指标证据质量为中级，其余均为低或极低级，导致降级最主要原因为研究的局限性（52个结局指标）和发表偏倚（45个结局指标）。 结论目前中医药治疗糖尿病周围神经病变疗效的系统评价/Meta分析方法学质量总体不高，证据水平普遍较低，今后的研究应严格按照循证医学科研设计思路进行，从而为中医药治疗糖尿病周围神经病变的临床疗效提供可靠证据。
Abstract:
ObjectiveTo re-evaluate system evaluation or Meta analysis of TCM therapy for diabetic peripheral neuropathy (DPN). MethodsThe literature on system evaluation or Meta analysis of TCM therapy for DPN was collected by retrieving from Pubmed, Cochrane Library, Web of science, Medline complete, CMB, CNKI, Wanfang and VIP. Two investigators indepently screened the literature and extracted the data, AMSTAR and GRADE system tools were used to assess the quality of methodology and evidence grades respectively. ResultsThe study included 13 papers on system evaluation or Meta analysis, containing 52 outcome indicators. The results of AMSTAR tool displayed that the worst item reported was "whether to provide the early-stage design"(unprovided in 12 papers), the next was the item "whether to consider searching grey literature" (inadequate in 11 papers) and the one "whether to illustrate conflict of interest" (unspecified in seven articles). GRADE classfication results showed that the evidence of five outcome indicators was of intermediate quality, and others were of low or very low quality, the main reasons of causing degradation were limitations of the study (53 outcome indicators) and publication bias (45 outcome indicators). ConclusionSince the methodological quality of system evaluation or Meta analysis of TCM therapy for DPN is generally not high, and the evidence is in lower level, the future studies should strictly be designed according to the idea of evidence-based medicine scientific research, thus providing reliable evidence for clinical efficacy of TCM therapy for DPN.

相似文献/References:

[1]段尚勤.糖脂消合罗格列酮治疗2型糖尿病合并非酒精性脂肪肝疗效观察[J].西部中医药,2013,26(02):88.
　DUAN Shangqin.Clinical Observation on TangZhiXiao and Rosiglitazone Maleate in Treating Type 2 Diabetes Mellitus Complicated with Non Alcoholic Fatty Liver Disease[J].Western Journal of Traditional Chinese Medicine,2013,26(11):88.
[2]张国民.消渴清颗粒治疗糖尿病周围神经病变疗效分析[J].西部中医药,2012,25(08):66.
　ZHANG Guo-min.XiaoKeQing Granules in Treating Diabetic Peripheral Neuropathy[J].Western Journal of Traditional Chinese Medicine,2012,25(11):66.
[3]张艳玲,高文菊.系统性干预对糖尿病并发症发生发展的影响[J].西部中医药,2013,26(12):81.
　ZHANG Yanling,GAO Wenju.Effects of Systematic Intervention on the Onset and Progression of Diabetic Complications[J].Western Journal of Traditional Chinese Medicine,2013,26(11):81.
[4]刘希宏.中西药物联用对老年高血压合并2型糖尿病患者肾功能的保护作用[J].西部中医药,2012,25(07):9.
　LIU Xi-hong.Protection of Integrated Traditional Chinese and Western Medicine on Renal Function of Patients with Senile Hypertension and Type 2 Diabetes Mellitus[J].Western Journal of Traditional Chinese Medicine,2012,25(11):9.
[5]呼宝娟.护理干预对肺结核合并糖尿病患者生活质量的影响[J].西部中医药,2013,26(09):125.
　HU Baojuan.Effects of Nursing Intervention on Life Quality of Diabetic Patients Complicated with Pulmonary Tuberculosis[J].Western Journal of Traditional Chinese Medicine,2013,26(11):125.
[6]梁伟.护理干预在2型糖尿病患者护理中的应用[J].西部中医药,2013,26(12):128.
　LIANG Wei.Application of Nursing Intervention to the Patients with Diabetes Mellitus Type 2[J].Western Journal of Traditional Chinese Medicine,2013,26(11):128.
[7]童玲利.外伤性跟骨骨折合并糖尿病患者围手术期护理体会[J].西部中医药,2014,27(02):131.
　TONG Lingli.Perioperative Care for the Patients with Diabetes Mellitus and Traumatic Calcaneal Fracture[J].Western Journal of Traditional Chinese Medicine,2014,27(11):131.
[8]付晓庆,李晓娟△.日常生活方式干预对糖尿病患者HbAlc及2hPBG的影响[J].西部中医药,2014,27(06):143.
　FU Xiaoqing,LI Xiaojuan.Influence of Daily Life Style Intervention on HbAlc and 2hPBG of the Patients with Diabetes Mellitus[J].Western Journal of Traditional Chinese Medicine,2014,27(11):143.
[9]齐丽丽,侯敏,尚新秀,等.2 型糖尿病患者八段锦锻炼态度的调查*[J].西部中医药,2014,27(08):36.
[10]牛建雄,王秀梅.糖尿病住院患者服药依从性现状分析[J].西部中医药,2014,27(08):67.
[11]张载宏.丹红注射液联合多贝斯治疗糖尿病周围神经病变临床疗效观察[J].西部中医药,2013,26(07):74.
　ZHANG Zaihong.Clinical Observation on DanHong Injection and Calcium Dobesilate Capsules in Treating Diabetic Peripheral Neuropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(11):74.
[12]段丽萍.中西医结合治疗糖尿病周围神经病变30例[J].西部中医药,2013,26(07):90.
　DUAN Liping.Integrative Medicine in Treating 30 Cases of Diabetic Peripheral Neuropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(11):90.
[13]陈海燕,刘怀珍.糖尿病周围神经病变的中医研究[J].西部中医药,2014,27(03):138.
　CHEN Haiyan,LIU Huaizhen.TCM Study of Diabetic Peripheral Neuropathy[J].Western Journal of Traditional Chinese Medicine,2014,27(11):138.

备注/Memo

备注/Memo:
钟琴（1994—），女，硕士学位，助教。研究方向：中医护理及老年护理。江西省中医药管理局科技计划项目（2020A0211）。
更新日期/Last Update: 2022-11-15